Artykuły w czasopismach na temat „Platinum compounds Therapeutic use”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Platinum compounds Therapeutic use”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Xiao, Xiao, James Trevor Oswald, Ting Wang, Weina Zhang i Wenliang Li. "Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery". Current Medicinal Chemistry 27, nr 18 (3.06.2020): 3055–78. http://dx.doi.org/10.2174/0929867325666181105115849.
Pełny tekst źródłaHassan Marouf, Bushra, i Mayyadah Mahmood Ali. "Prevention and Management of Platinum Compounds-Induced Neurotoxicity". Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 1 (22.11.2021): 102–9. http://dx.doi.org/10.54133/ajms.v1i.43.
Pełny tekst źródłaMakovec, Tomaz. "Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy". Radiology and Oncology 53, nr 2 (28.03.2019): 148–58. http://dx.doi.org/10.2478/raon-2019-0018.
Pełny tekst źródłaJurgens, Sophie, Fritz E. Kuhn i Angela Casini. "Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives". Current Medicinal Chemistry 25, nr 4 (12.02.2018): 437–61. http://dx.doi.org/10.2174/0929867324666170529125229.
Pełny tekst źródłaRoszczenko, Piotr, Olga Klaudia Szewczyk, Robert Czarnomysy, Krzysztof Bielawski i Anna Bielawska. "Biosynthesized Gold, Silver, Palladium, Platinum, Copper, and Other Transition Metal Nanoparticles". Pharmaceutics 14, nr 11 (25.10.2022): 2286. http://dx.doi.org/10.3390/pharmaceutics14112286.
Pełny tekst źródłaWimberger, Pauline, Barbara Klink, Konrad Gruetzmann, Julian Puppe, Daniel Klotz, Evelin Schroeck, Jan Dominik Kuhlmann i Sarah Schott. "The activity of the conjugated antimetabolite 5-FdU-ECyd against platinum-resistant ovarian cancer." Journal of Clinical Oncology 35, nr 15_suppl (20.05.2017): e17077-e17077. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e17077.
Pełny tekst źródłaMaiorano, Brigida Anna, Ugo De Giorgi, Davide Ciardiello, Giovanni Schinzari, Antonio Cisternino, Giampaolo Tortora i Evaristo Maiello. "Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day". Biomedicines 10, nr 2 (9.02.2022): 411. http://dx.doi.org/10.3390/biomedicines10020411.
Pełny tekst źródłaMarcu, Loredana G. "Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds". Pharmaceuticals 15, nr 2 (20.02.2022): 255. http://dx.doi.org/10.3390/ph15020255.
Pełny tekst źródłaFaraoni, Isabella, i Grazia Graziani. "Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors". Cancers 10, nr 12 (4.12.2018): 487. http://dx.doi.org/10.3390/cancers10120487.
Pełny tekst źródłaKrasnopolsky, Yu, D. Pylypenko i G. Grigoryeva. "NANOMEDICINE IN ANTICANCER THERAPY". Bulletin of the National Technical University "KhPI". Series: Chemistry, Chemical Technology and Ecology 1, nr 7 (30.12.2022): 3–13. http://dx.doi.org/10.20998/2079-0821.2022.01.
Pełny tekst źródłaVarela-Castillo, O., P. Cordero, G. Gutiérrez-Iglesias, I. Palma, I. Rubio-Gayosso, E. Meaney, I. Ramirez-Sanchez, F. Villarreal, G. Ceballos i N. Najera. "CHARACTERIZATION OF THE CYTOTOXIC EFFECTS OF THE COMBINATION OF CISPLATIN AND FLAVANOL (-)-EPICATECHIN ON HUMAN LUNG CANCER CELL LINE A549. AN ISOBOLOGRAPHIC APPROACH". Experimental Oncology 40, nr 1 (22.03.2018): 19–23. http://dx.doi.org/10.31768/2312-8852.2018.40(1):19-23.
Pełny tekst źródłaP., Pramila, Anju Abraham, Sunita Pawar, Vibha Bafna i Monika S. Bansal. "TO STUDY THE THERAPEUTIC MANAGEMENT, DRUG RELATED PROBLEMS AND CONCOMITANT USE OF DRUGSIN PATIENTS WITH CANCER". International Journal of Pharmacy and Pharmaceutical Sciences 9, nr 6 (1.06.2017): 139. http://dx.doi.org/10.22159/ijpps.2017v9i6.18207.
Pełny tekst źródłaGonzález-García, J., B. Alonso-Alvarez, GJ Nazco-Casariego, N. Batista-López i F. Guttiérrez-Nicolás. "Plasma levels of trastuzumab in gastric cancer: Case report". Journal of Oncology Pharmacy Practice 23, nr 8 (23.09.2016): 635–37. http://dx.doi.org/10.1177/1078155216670228.
Pełny tekst źródłaDasari, Shaloam, Sylvianne Njiki, Ariane Mbemi, Clement G. Yedjou i Paul B. Tchounwou. "Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy". International Journal of Molecular Sciences 23, nr 3 (28.01.2022): 1532. http://dx.doi.org/10.3390/ijms23031532.
Pełny tekst źródłaLothstein, Leonard, Judith Soberman, Deanna Parke, Jatin Gandhi, Trevor Sweatman i Tiffany Seagroves. "Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo". Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28, nr 5 (10.12.2020): 451–65. http://dx.doi.org/10.3727/096504020x15898794315356.
Pełny tekst źródłaBarr, Ronald D., Dawn Chalmers, Sonja De Pauw, William Furlong, Sheila Weitzman i David Feeny. "Health-Related Quality of Life in Survivors of Wilms’ Tumor and Advanced Neuroblastoma: A Cross-Sectional Study". Journal of Clinical Oncology 18, nr 18 (18.09.2000): 3280–87. http://dx.doi.org/10.1200/jco.2000.18.18.3280.
Pełny tekst źródłaPrasad, Sahdeo, Dan DuBourdieu, Ajay Srivastava, Prafulla Kumar i Rajiv Lall. "Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin". International Journal of Molecular Sciences 22, nr 13 (30.06.2021): 7094. http://dx.doi.org/10.3390/ijms22137094.
Pełny tekst źródłaBossi, P., D. Parolini, C. Bergamini, L. D. Locati, E. Orlandi, M. Franceschini, M. Palazzi, P. Olmi, P. Potepan i L. Licitra. "TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC)". Journal of Clinical Oncology 27, nr 15_suppl (20.05.2009): 6046. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.6046.
Pełny tekst źródłaBryde, Susanne, i Anton IPM de Kroon. "Nanocapsules of platinum anticancer drugs: development towards therapeutic use". Future Medicinal Chemistry 1, nr 8 (listopad 2009): 1467–80. http://dx.doi.org/10.4155/fmc.09.112.
Pełny tekst źródłaSoejima, Takashi, i Kei-ji Iwatsuki. "Innovative Use of Palladium Compounds To Selectively Detect Live Enterobacteriaceae in Milk by PCR". Applied and Environmental Microbiology 82, nr 23 (23.09.2016): 6930–41. http://dx.doi.org/10.1128/aem.01613-16.
Pełny tekst źródłaWoźniak, Katarzyna, i Zofia Walter. "Induction of DNA-Protein Cross-Links by Platinum Compounds". Zeitschrift für Naturforschung C 55, nr 9-10 (1.10.2000): 731–36. http://dx.doi.org/10.1515/znc-2000-9-1010.
Pełny tekst źródłaRébé, Cédric, Lucie Demontoux, Thomas Pilot i François Ghiringhelli. "Platinum Derivatives Effects on Anticancer Immune Response". Biomolecules 10, nr 1 (20.12.2019): 13. http://dx.doi.org/10.3390/biom10010013.
Pełny tekst źródłaReedijk, Jan. "Increased understanding of platinum anticancer chemistry". Pure and Applied Chemistry 83, nr 9 (31.03.2011): 1709–19. http://dx.doi.org/10.1351/pac-con-10-11-03.
Pełny tekst źródłaFarrell, Nicholas P. "Preclinical perspectives on the use of platinum compounds in cancer chemotherapy". Seminars in Oncology 31 (grudzień 2004): 1–9. http://dx.doi.org/10.1053/j.seminoncol.2004.11.004.
Pełny tekst źródłaMaillard, Maud, Félicien Le Louedec, Fabienne Thomas i Etienne Chatelut. "Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review". Expert Opinion on Drug Metabolism & Toxicology 16, nr 10 (2.10.2020): 907–25. http://dx.doi.org/10.1080/17425255.2020.1789590.
Pełny tekst źródłaDomínguez-Jurado, Elena, Francisco J. Cimas, José Antonio Castro-Osma, Alberto Juan, Agustín Lara-Sánchez, Antonio Rodríguez-Diéguez, Alexandr Shafir, Alberto Ocaña i Carlos Alonso-Moreno. "Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer". Pharmaceutics 13, nr 10 (26.09.2021): 1559. http://dx.doi.org/10.3390/pharmaceutics13101559.
Pełny tekst źródłaBoussaad, Ibrahim, Andriana Kotini, Emily K. Dolezal, Stephen Nimer i Eirini P. Papapetrou. "An iPSC-Based Model Of MDS For Phenotype-Driven Gene and Drug Discovery". Blood 122, nr 21 (15.11.2013): 859. http://dx.doi.org/10.1182/blood.v122.21.859.859.
Pełny tekst źródłaTurkson, James, Shumin Zhang, Jay Palmer, Heidi Kay, Joseph Stanko, Linda B. Mora, Said Sebti, Hua Yu i Richard Jove. "Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity". Molecular Cancer Therapeutics 3, nr 12 (1.12.2004): 1533–42. http://dx.doi.org/10.1158/1535-7163.1533.3.12.
Pełny tekst źródłaRomano, Alberto, Michele Antonio Capozza, Stefano Mastrangelo, Palma Maurizi, Silvia Triarico, Rolando Rolesi, Giorgio Attinà, Anna Rita Fetoni i Antonio Ruggiero. "Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer". Cancers 12, nr 5 (17.05.2020): 1266. http://dx.doi.org/10.3390/cancers12051266.
Pełny tekst źródłaAli, Mayyadah Mahmood, i Tavga Ahmed Aziz. "Toxic Effect of Platinum Compounds: Molecular Mechanisms of Toxicity". Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 1 (30.10.2021): 81–88. http://dx.doi.org/10.54133/ajms.v1i.32.
Pełny tekst źródłaAdokoh, Christian K. "Therapeutic potential of dithiocarbamate supported gold compounds". RSC Advances 10, nr 5 (2020): 2975–88. http://dx.doi.org/10.1039/c9ra09682e.
Pełny tekst źródłaSamochocka, K., i M. Czauderna. "Use of INAA to study the biodistribution of platinum compounds in animals". Journal of Radioanalytical and Nuclear Chemistry Letters 106, nr 3 (sierpień 1986): 153–57. http://dx.doi.org/10.1007/bf02166785.
Pełny tekst źródłaKushner, Brian H., Amy Budnick, Kim Kramer, Shakeel Modak i Nai-Kong V. Cheung. "Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma". Cancer 107, nr 2 (2006): 417–22. http://dx.doi.org/10.1002/cncr.22004.
Pełny tekst źródłaHerman, Terence S., Beverly A. Teicher, Lynn Van Ummersen i Laura S. Collins. "Synthesis and testing of new platinum-based compounds for use with hyperthermia". International Journal of Radiation Oncology*Biology*Physics 13 (październik 1987): 165–66. http://dx.doi.org/10.1016/0360-3016(87)91161-8.
Pełny tekst źródłaCharignon, Elsa, Mathilde Bouché, Caroline Clave-Darcissac, Georges Dahm, Gabriel Ichim, Anthony Clotagatide, Hichem C. Mertani i in. "In Cellulo Evaluation of the Therapeutic Potential of NHC Platinum Compounds in Metastatic Cutaneous Melanoma". International Journal of Molecular Sciences 21, nr 21 (22.10.2020): 7826. http://dx.doi.org/10.3390/ijms21217826.
Pełny tekst źródłaSchweer, David, J. Robert McCorkle, Jurgen Rohr, Oleg V. Tsodikov, Frederick Ueland i Jill Kolesar. "Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer". Biomedicines 9, nr 1 (12.01.2021): 70. http://dx.doi.org/10.3390/biomedicines9010070.
Pełny tekst źródłaLam, Chui, i Kai Chow. "Use of New Therapeutic Compounds in Pregnancy with Renal Disease". Current Women's Health Reviews 1, nr 3 (1.11.2005): 197–200. http://dx.doi.org/10.2174/157340405774575196.
Pełny tekst źródłaStojic, Isidora, Vladimir Zivkovic, Ivan Srejovic, Nevena Jeremic, Vladimir Jakovljevic, Dragan Djuric i Slobodan Novokmet. "The Effects of Cisplatin and Its PT(II) Analogue on Oxidative Stress of Isolated Rat Heart/ Efekti Cisplatine I PT(II) Analoga Cisplatine Na Oksidacioni Stres Izolovanog Srca Pacova". Serbian Journal of Experimental and Clinical Research 17, nr 1 (1.03.2016): 15–20. http://dx.doi.org/10.1515/sjecr-2015-0050.
Pełny tekst źródłaBuyana, Buhle, Tobeka Naki, Sibusiso Alven i Blessing Atim Aderibigbe. "Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy". International Journal of Molecular Sciences 23, nr 19 (24.09.2022): 11261. http://dx.doi.org/10.3390/ijms231911261.
Pełny tekst źródłaDag, Aydan, Manuela Callari, Hongxu Lu i Martina H. Stenzel. "Modulating the cellular uptake of platinum drugs with glycopolymers". Polymer Chemistry 7, nr 5 (2016): 1031–36. http://dx.doi.org/10.1039/c5py01579k.
Pełny tekst źródłaBernocchi, G., M. G. Bottone, V. M. Piccolini, V. Dal Bo, G. Santin, S. A. De Pascali, D. Migoni i F. P. Fanizzi. "Developing Central Nervous System and Vulnerability to Platinum Compounds". Chemotherapy Research and Practice 2011 (15.02.2011): 1–14. http://dx.doi.org/10.1155/2011/315418.
Pełny tekst źródłaVillalba, Jose M., Cristina Parrado, Monica Santos-Gonzalez i Francisco J. Alcain. "Therapeutic use of coenzyme Q10and coenzyme Q10-related compounds and formulations". Expert Opinion on Investigational Drugs 19, nr 4 (31.03.2010): 535–54. http://dx.doi.org/10.1517/13543781003727495.
Pełny tekst źródłaKhokhlova, S. V., M. V. Cherkasova, N. F. Orel, S. V. Limareva, I. Ya Bazaeva i V. A. Gorbunova. "WHICH PATIENTS WITH OVARIAN CANCER SHOWS THE COMBINATION OF TRABECTEDIN WITH PEGYLATED LIPOSOMAL DOXORUBICIN". Annals of the Russian academy of medical sciences 68, nr 11 (12.11.2013): 115–21. http://dx.doi.org/10.15690/vramn.v68i11.852.
Pełny tekst źródłaKöberle, Beate, i Sarah Schoch. "Platinum Complexes in Colorectal Cancer and Other Solid Tumors". Cancers 13, nr 9 (25.04.2021): 2073. http://dx.doi.org/10.3390/cancers13092073.
Pełny tekst źródłaRonchi, Cristina L., Silviu Sbiera, Luitgard Kraus, Sebastian Wortmann, Sarah Johanssen, Patrick Adam, Holger S. Willenberg, Stefanie Hahner, Bruno Allolio i Martin Fassnacht. "Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy". Endocrine-Related Cancer 16, nr 3 (wrzesień 2009): 907–18. http://dx.doi.org/10.1677/erc-08-0224.
Pełny tekst źródłaSoejima, Takashi, Jun-ichi Minami, Jin-zhong Xiao i Fumiaki Abe. "Innovative use of platinum compounds to selectively detect live microorganisms by polymerase chain reaction". Biotechnology and Bioengineering 113, nr 2 (19.08.2015): 301–10. http://dx.doi.org/10.1002/bit.25711.
Pełny tekst źródłaSzefler, Beata, Przemysław Czeleń i Przemysław Krawczyk. "The Affinity of Carboplatin to B-Vitamins and Nucleobases". International Journal of Molecular Sciences 22, nr 7 (31.03.2021): 3634. http://dx.doi.org/10.3390/ijms22073634.
Pełny tekst źródłaVenturella, Giuseppe, Valeria Ferraro, Fortunato Cirlincione i Maria Letizia Gargano. "Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials". International Journal of Molecular Sciences 22, nr 2 (10.01.2021): 634. http://dx.doi.org/10.3390/ijms22020634.
Pełny tekst źródłaVenturella, Giuseppe, Valeria Ferraro, Fortunato Cirlincione i Maria Letizia Gargano. "Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials". International Journal of Molecular Sciences 22, nr 2 (10.01.2021): 634. http://dx.doi.org/10.3390/ijms22020634.
Pełny tekst źródłaShoji, Eto, Sato, Soma, Fukagawa, Tomabechi, Takatori i in. "A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease". Healthcare 7, nr 3 (19.09.2019): 109. http://dx.doi.org/10.3390/healthcare7030109.
Pełny tekst źródła